1- 2- , , , , ,
Both GIPR co-agonism (as in tirzepatide) and GIPR antagonism (as in MariTide, a bispecific hybrid molecule comprising two GLP-1R agonist peptides conjugated to a monoclonal anti-GIPR antagonistic antibody) are effective in treating people living with obesity 2,3,22
Significant temporal changes in hippocampal neurochemical profile were observed in both ipsilateral and contralateral hippocampus in TBI-injured rats (Tables 2 and 3)
The weight youve lost and the metabolic improvements youve achieved on GLP-1s give you a better starting point for pregnancy than you had beforethats worth celebrating, even as you navigate the complexities of the washout period and conception timing
[DOI] [PMC free article] [PubMed] [Google Scholar] 88.Egawa T., Goto A., Ohno Y., Yokoyama S., Ikuta A., Suzuki M., Sugiura T., Ohira Y., Yoshioka T., Hayashi T., et al